Hand surgery outreach programs to low- and middle-income countries (LMICs) provide much-needed surgical care to the underserved populations and education to local providers for improved care. The cost-effectiveness of these surgical trips has not been studied despite a long history of such efforts. This study aimed to examine the economic impact of hand surgery trips to LMICs using data from the Touching Hands Project and ReSurge International. We hypothesized that hand surgery outreach would be cost-effective in LMICs.
We analyzed data on the cost of each trip and the surgical procedures performed. Using methods from the World Health Organization (WHO–Choosing Interventions That Are Cost-Effective [WHO-CHOICE]), we determined whether the procedures performed during the outreach trips would be cost-effective.
For the 14 hand surgery trips, 378 patients received surgical treatment. Trips varied in the country where interventions were provided, the number of patients served, the severity of the conditions, and the total cost. The cost per disability-adjusted life-year averted ranged from United States (US)$222 to $1,525, all of which were very cost-effective according to WHO-CHOICE thresholds. The cost-effectiveness of global hand surgery was comparable to that of other medical interventions such as multidrug-resistant tuberculosis treatment in similar regions. We also identified a lack of standardized record keeping for these surgical trips.
Hand surgeries performed in LMICs are cost-effective based on WHO-CHOICE criteria. However, a standardized record-keeping method is needed for future research and longitudinal comparison. Understanding the economic impact of hand surgery global outreach is important to the success and sustainability of these efforts, both to allocate resources effectively and to identify areas for improvement.
Type of study/level of evidence
Economic/Decision Analysis III.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Hand Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Global economic consequences of selected surgical diseases: a modelling study.Lancet Glob Health. 2015; 3: S21-S27
- Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development.Lancet Glob Health. 2015; 386: 569-624
- Quality assurance guidelines for surgical outreach programs: a 20-year experience.Cleft Palate J. 2008; 45: 246-255
- Disease Control Priorities in Developing Countries.World Bank Publications, Washington, DC2006
- A model for building capacity in international plastic surgery: ReSurge International.Ann Plast Surg. 2011; 67: 568-570
- The richness of caring for the poor: the development and implementation of the Touching Hands Project.J Hand Surg Am. 2015; 40: 566-575
- The role for international outreach in hand surgery.J Hand Surg Am. 2017; 42: 652-655
- About us.(Available at:)Accessed February 1, 2018)
- What we do.(Available at:)Accessed May 5, 2018)
- The economics of global health: an assessment.Oxford Review of Economic Policy. 2016; 32: 1-20
- Global health funding and economic development.Global Health. 2012; 8: 8
- Financing Global Health: Viz Hub.(Available at:)Accessed May 5, 2018)
- Measuring and comparing the cost-effectiveness of surgical care delivery in low-resource settings: cleft lip and palate as a model.J Craniofac Surg. 2015; 26: 1121-1125
- The impact and cost-effectiveness of the Amref Health Africa-Smile Train Cleft Lip and Palate Surgical Repair Programme in Eastern and Central Africa.Pan Afr Med J. 2017; 28: 35
- Helping Hands: a cost-effectiveness study of a humanitarian hand surgery mission.Plast Surg Int. 2014; 2014: 921625
- Development of WHO guidelines on generalized cost-effectiveness analysis.Health Econ. 2000; 9: 235-251
- The WHO-CHOICE cost-effectiveness threshold: a country-level analysis of changes over time.Value Health. 2015; 18: A88
- World Health Organization Geneva. WHO guide to cost-effectiveness analysis.(Available at:)Accessed September 27, 2017)
- Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries.BMJ. 2005; 331: 1107
- The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study.PLoS Med. 2012; 9e1001323
- Cost-effectiveness of a locally organized surgical outreach mission: making a case for strengthening local non-governmental organizations.World J Surg. 2017; 41: 3074-3082
- Cost-effectiveness analysis of cataract surgery: a global and regional analysis.Bull World Health Organ. 2004; 82: 338-345
- A systematic review of economic analysis of surgical mission trips using the World Health Organization criteria.World J Surg. 2016; 40: 1874-1884
- Visiting Educator Program.(Available at:)Accessed May 5, 2018)
- Consumer Price Index (CPI) databases.(Available at:)Accessed May 5, 2018)
- Understanding DALYs.J Health Econ. 1997; 16: 703-730
- QALYs vs DALYs vs LYs gained: what are the differences, and what difference do they make for health care priority setting?.Norsk Epidemiol. 2005; 15: 217
- HALYS and QALYS and DALYS, oh my: similarities and differences in summary measures of population health.Annu Rev Public Health. 2002; 23: 115-134
- DALYs and QALYs in developing countries.Health Aff. 2007; 26: 1197-1198
- Calculating disability-adjusted life years (DALY) as a measure of excess cancer risk following radiation exposure.J Radiol Prot. 2015; 35: 763-765
- Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis.Health Policy Plan. 2001; 16: 326-331
- Mortality by cause for eight regions of the world: Global Burden of Disease Study.Lancet Glob Health. 1997; 349: 1269-1276
- Global Burden of Disease Study.Institute for Health Metrics and Evaluation (IHME), 2016 (Available at:)Accessed January 15, 2018)
- Global Health Observatory data repository.(Available at:)Accessed May 5, 2018)
- Comparing the cost-effectiveness of short orthopedic missions in elective and relief situations in developing countries.World J Surg. 2011; 35: 951-955
- GDP per capita.(Available at:)Accessed May 5, 2018)
- Country-level cost-effectiveness thresholds: initial estimates and the need for further research.Value Health. 2016; 19: 929-935
- A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis.Pharmacoeconomics. 2012; 30: 63-80
- Cleft lip and palate as a cost-effective health care treatment in the developing world.World J Surg. 2010; 34: 420-427
- Enhancing neurosurgical education in low- and middle-income countries: current methods and new advances.Neurol Med Chir. 2016; 56: 709-715
- Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence.Lancet Glob Health. 2002; 359: 1635-1643
- Cost-effectiveness analysis of malaria interventions using disability adjusted life years: a systematic review.Cost Eff Resour Alloc. 2017; 15: 10
- Access to surgical care in developing countries.JAMA Surg. 2016; 151: 263-264
- Global surgical initiatives to reduce the surgical burden of disease.JAMA. 2012; 307: 667-668
- Funding allocation to surgery in low and middle-income countries: a retrospective analysis of contributions from the USA.BMJ Open. 2015; 5e008780
Published online: December 20, 2018
Accepted: October 31, 2018
Received: July 2, 2018
No benefits in any form have been received or will be received related directly or indirectly to the subject of this article.
© 2019 by the American Society for Surgery of the Hand. All rights reserved.